TEGOPEN INJ 250MG/VIAL
TEGOPEN INJ 250MG/VIAL
Discontinued
DIN Number
00407593
Drug Class
Human
Market Date
Dec 31, 1973
Company
HC
bristol labs division of bristol-myers squibb
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00407593
AIG Number0105904001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01CF02 CLOXACILLIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
,
Intravenous
AHFS Classification08:12.16.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
CLOXACILLIN SODIUMActive
Strength: 250 MG / VIAL
Monograph: CLOXACILLIN SODIUM